RXRushan Xia

Rushan Xia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rushan Xia has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Xiaohong Zhu

    Department of Dermatology Wuxi No.2 People's Hospital Wuxi Jiangsu Province China

    4 shared publications
  • Yunmin Zou

    Department of Dermatology

    3 shared publications
  • Jing Gu

    Department of Dermatology, The Affiliated Wuxi No. 2 People’s Hospital of Nanjing Medical University, Wuxi, China

    2 shared publications
  • Lei Cao

    Department of Dermatology, The Affiliated Wuxi No. 2 People’s Hospital of Nanjing Medical University, Wuxi, China

    2 shared publications
  • Lijia Yang

    Department of Dermatology, Wuxi Second Affiliated Hospital of Nanjing Medical University, Wuxi, China

    2 shared publications
  • Yinni Ma

    Department of Dermatology, The Affiliated Wuxi No. 2 People’s Hospital of Nanjing Medical University, Wuxi, China

    2 shared publications

Latest Publications

  • Open Access

    Investigating the potential mechanism of microneedling in alopecia areata mice based on 16S rRNA sequencing and metabolomics

    by Yue Zhang, Lu Li, Lei Cao, Rushan Xia

    Background: The present study investigates the relationship between alopecia areata (AA) and intestinal microecology, examining the effect of microneedling on the microecology of alopecia areata.Methods: An animal model of AA was established using imiquimod-induced C3H/HeJ mice. Halometasone was applied topically every 2 days for 2 weeks after a hand-held dermal microneedling treatment. Fecal samples were collected before and after the interventions and underwent 16S rRNA high-throughput sequencing to assess intestinal microecological alterations. Furthermore, changes in short-chain fatty acids (SCFA) associated with AA and microneedling treatment were analyzed.Results: Microneedling therapy enhanced hair growth in the model group. The model group exhibited a substantial decline in diversity and abundance of gut microbes compared to the control group. After microneedling treatment, the diversity of intestinal microbes was restored, along with a concurrent remodeling of both pathogenic and beneficial bacterial compositions in the model group. In addition, the levels of acetic acid and propanoic acid were elevated in the model group compared to the control group. Following microneedling treatment, a reduction in these levels was observed. In contrast, the model group showed an increase in butanoic acid levels after microneedling treatment; however, this increase did not reach statistical significance.Conclusion: Microneedling treatment has been shown to improve hair regeneration in AA. Additionally, it positively affects the intestinal microecology related to AA, leading to changes in gut microbes and the production of SCFAs. This provides a foundation for the clinical application of microneedling treatment in AA.


  • Open Access

    Refractory Segmental Hyaline Vasculitis Treated with Janus Kinase Inhibitor Tofacitinib: A Case Report

    by Yue Zhang, Rushan Xia

    This article reports a 59-year-old female patient who was diagnosed with segmental hyaline vasculitis and treated with tofacitinib for 2 months. In this case, multiple dark purplish-red spots were seen on both lower limbs, which did not fade with pressure. Flaky dark red spots, petechiae, ulcers, and necrosis were seen on the ankles. Histopathological manifestations were consistent with segmental hyaline vasculitis. The lesions subsided after the patient was treated with oral tofacitinib 5 mg twice daily for 1 month.

  • Open Access

    Concordance between reflectance confocal microscopy and histopathology for the diagnosis of acral lentiginous melanoma

    by Yunmin Zou, Xiaohong Zhu, Rushan Xia

    Background: Acral lentiginous melanoma (ALM) is a highly malignant and invasive type of melanoma with unique locations of onset. Its incidence is increasing and early diagnosis is challenging. Reflectance confocal microscopy (RCM) is a non‐invasive technique that provides an accurate image of tissue pathology. There are few reports on the use of RCM for the assessment of ALM.Materials and methods: In this retrospective study, data from 31 patients with a clinical diagnosis of ALM were collected. RCM image features were compared with histopathological findings to determine the concordance between the two methods. The sensitivity, specificity, positive predictive value, and negative predictive value of RCM for the diagnosis of ALM were evaluated.Results: RCM and histopathology findings were concordant in 29 of 31 patients (93.5%). There were no false‐negative results, although there were two false positives in RCM diagnosis. The sensitivity of RCM for diagnosing ALM was 100%, specificity was 50%, positive predictive value was 93.1%, and negative predictive value was 100%.Conclusions: RCM showed substantial concordance with histopathology in the diagnosis of ALM. It is a reliable and valuable non‐invasive diagnostic tool that holds promise for the early diagnosis of ALM.


  • Open Access

    Reflectance confocal microscopy follow-up of multifocal superficial basal cell carcinomas treated with imiquimod 5% cream

    by Yun-Min Zou, Xiaohong Zhu, Rushan Xia

    Background: Patients with multifocal superficial basal cell carcinomas (sBCC) require a non-invasive treatment and follow-up with a non-invasive technique. Imiquimod 5% cream is a new non-invasive therapy for BCC. Reflectance confocal microscopy (RCM) is a non-invasive, real-time imaging technique. Methods:The efficacy of imiquimod 5% cream for the treatment of multifocal sBCC was evaluated, as well as the potential of RCM for assessing therapeutic effects. We reported four patients with 34 sBCC lesions were treated with imiquimod 5% cream. RCM was performed in the baseline and at 12 weeks, 24 weeks and 52 weeks after starting treatment. Results: Of 34 lesions treated with imiquimod 5%, 32 responded to the treatment and showed complete clinical clearing. Two subclinical BCC lesions were identified by RCM. The complete tumor clearance rate was 88.2%, and the efficiency rate was 97.1%. No lesion recurred at 24-month follow-up. RCM identified previously described confocal features of BCC and was more sensitive than clinical examination. Local skin reactions were relieved after expectant treatment. Conclusions: Imiquimod 5% cream may be useful for the treatment of multifocal sBCC, and its side effects are easy to manage. RCM can be used for non-invasive monitoring of treatment response and improved the tumor clearance rate.


  • Open Access

    Neural progenitor cell-derived nanovesicles promote hair follicle growth via miR-100

    by Lei Cao, Tian Tian, Yuanbo Huang, Shiqin Tao, Xiaohong Zhu, Mifang Yang, Jing Gu, Guangdong Feng, Yinni Ma, Rushan Xia, et al.

    Background: Accumulating evidence shows that mesenchymal stem cell-derived extracellular vesicles (EVs) hold great promise to promote hair growth. However, large-scale production of EVs is still a challenge. Recently, exosome-mimetic nanovesicles (NV) prepared by extruding cells have emerged as an alternative strategy for clinical-scale production. Here, ReNcell VM (ReN) cells, a neural progenitor cell line was serially extruded to produce NV. Results: ReN-NV were found to promote dermal papilla cell (DPC) proliferation. In addition, in a mouse model of depilation-induced hair regeneration, ReN-NV were injected subcutaneously, resulting in an acceleration of hair follicle (HF) cycling transition at the site. The underlying mechanism was indicated to be the activation of Wnt/β-catenin signaling pathway. Furthermore, miR-100 was revealed to be abundant in ReN-NV and significantly up-regulated in DPCs receiving ReN-NV treatment. miR-100 inhibition verified its important role in ReN-NV-induced β-catenin signaling activation. Conclusion: These results provide an alternative agent to EVs and suggest a strategy for hair growth therapy.


  • Pigmented mammary Paget disease mimicking melanoma on reflectance confocal microscopy

    by Yunmin Zou, Xiaohong Zhu, Lijia Yang, Jing Gu, Rushan Xia


  • Open Access

    Role of Annexin A2 isoform 2 on the aggregative growth of dermal papillae cells

    by Jing Gu, Yinni Ma, Lijia Yang, Feng Wang, Cao Lei, Jianxin Zhai, Rushan Xia

    The dermal papilla is a major component of hair, which signals the follicular epithelial cells to prolong the hair growth process. Human Annexin A2 was preliminarily identified by two-dimensional gel electrophoresis (2-DE), MALDI-TOF-MS and database searching. The aim of the present study was to explore the role of Annexin A2 in the aggregative growth of dermal papillae cells (DPC). Reverse transcription-polymerase chain reaction (RT-PCR) and Western blot were adopted to detect the expression of Annexin A2. And siRNA technique was used to suppress the expression of Annexin A2. Construction of over-expression vector was used to up-regulate the expression of Annexin A2. Cell Counting Kit 8 (CCK-8) and proliferating cell nuclear antigen (PCNA) were taken to detect the proliferation of DPC. The expression of Annexin A2 mRNA was up-regulated in passage 3 DPC compared with passage 10 DPC by RT-PCR. In line with the results at the mRNA level, Western blot analysis revealed that Annexin A2 isoform 2 was up-regulated significantly in passage 3 DPC compared with passage 10 DPC. The Annexin A2 isoform 2 siRNA was synthesized and transfected into passage 3 DPC. RT-PCR data showed the mRNA expression of Annexin A2 isoform 2 was suppressed in passage 3 DPC. Western blot results showed the expression level of Annexin A2 isoform 2 and PCNA were suppressed in passage 3 DPC. CCK-8 results showed that the proliferation of passage 3 DPC was suppressed (P < 0.05). Recombinant plasmid PLJM-Annexin A2 isoform 2-expression vector were constructed and were transfected into passage 10 DPC. RT-PCR data showed the mRNA expression of Annexin A2 isoform 2 was up-regulated in passage 10 DPC. Western blot results showed the expression level of annexin A2 isoform 2 and PCNA were up-regulated in passage 10 DPC. CCK-8 assay showed the proliferation of DPC was stimulated compared with control group (*P < 0.05). Our study proved that Annexin A2 isoform 2 may participate in regulating the proliferation of DPC and may be related to aggregative growth of dermal papilla cells. Therefore, our study suggests that Annexin A2 may be linked to hair follicle growth cycle.